Author:
Tiam Eric Robert,Bikobo Dominique Serge Ngono,Ndassa Ibrahim Mbouombouo,Nyemeck II Norbert Mbabi,A Zintchem Auguste Abouem,Ayong Lawrence,Diboué Patrick Hervé Betote,Ndjakou Bruno Lenta,Mbing Joséphine Ngo,Pegnyemb Dieudonné Emmanuel
Abstract
Abstract
Background
Chemical and pharmacological investigations were performed on the stems of Cordia batesii (Boraginaeae); chemical studies included quantum calculations applied on a newly described compound.
Results
A new derivative of allantoin (1) named batesiin (2) was characterized. Thirteen other known compounds involving allantoin (1) were either isolated or identified. GC–MS enabled the identification of six compounds from a fraction containing essential oil. MeOH extract and some isolated compounds were tested in vitro against Pf7G8 CQS and Pf Dd2 CQR strains of Plasmodium falciparum; extract disclosed a moderate antiplasmodial activity (IC50 = 50 μg mL−1). Meantime, the CH2Cl2 extract and essential oil fraction were tested on a resistant mycobacterial strain of Mycobacterium tuberculosis; a potent antimycobacterial activity with a MIC = 9.52 μg mL−1 was deduced from essential oil. Density functional theory (DFT) calculations were carried on batesiin (2). Calculated chemical shifts at B3LYP/6-31G(d,p) and MPW1PW91/6-31G+(d,p) showed much better correlations with the experimental data. Time dependent DFT at B3LYP/6-31G+(d,p) displayed a major absorption band 3.01 nm higher than the experimental value.
Conclusion
Cordia batesii can be considered as promising in search of compounds with antimalarial and antitubercular properties. DFT studies are very helpful when trying to learn more about the spectroscopic insights of a derivative of allantoin (1).
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. World Health Organization. Accelerating progress on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases: a new agenda for 2016–2030. 2015. World Health Organization. https://apps.who.int/iris/handle/10665/204419. Accessed 15 Sept 2020.
2. Rasmussen C, Nyunt MM, Ringwald P (2017) Artemisinin-resistant Plasmodium falciparum in Africa. N Engl J Med 377:305–306
3. Houben RM, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13:e1002152
4. Der Meeren OV, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E et al (2018) Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis. N Engl J Med 379:1621–1634
5. World malaria report. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献